Page last updated: 2024-08-21

triflusal and 11-dehydro-thromboxane b2

triflusal has been researched along with 11-dehydro-thromboxane b2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avellone, G; Ballone, E; Ciabattoni, G; Davì, G; Di Febbo, C; Di Nicola, M; Falco, A; Pinto, A; Salvati, F; Vitacolonna, E	1

Trials

1 trial(s) available for triflusal and 11-dehydro-thromboxane b2

Article	Year
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. Atherosclerosis, 2005, Volume: 183, Issue:2 Topics: Adult; Aged; Aspirin; Biomarkers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Radioimmunoassay; Retrospective Studies; Salicylates; Thromboxane B2; von Willebrand Factor	2005

Article

Year

Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus.

Atherosclerosis, 2005, Volume: 183, Issue:2

Topics: Adult; Aged; Aspirin; Biomarkers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Radioimmunoassay; Retrospective Studies; Salicylates; Thromboxane B2; von Willebrand Factor

2005